Cholesterol-Lowering Effects and Mechanisms in View of Bile Acid Pathway of Resveratrol and Resveratrol Glucuronides

Journal of Food Science

Volumn 81, Issue 11, 2016, Pages H2841-H2848

  Shao, Dongyan ^a   Wang, Yilin ^a   Huang, Qingsheng ^a   Shi, Junling ^a   Yang, Hui ^a   Pan, Zhongli ^b,c   Jin, Mingliang ^a   Zhao, Haobin ^a   Xu, Xiaoguang ^a  

^a NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^b Univ of California   (United States)

^c WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

bile acid; cholesterol lowering; excretion; resveratrol; resveratrol glucuronide

Indexed keywords

EID: 84991309774     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.13528     Document Type: Article

References (34)

1. Bai J. 2012. The influence of redox state and liver gene expression by resveratrol in high fat induced obesity and anti-obesity KM mice. Jiangnan University.
2. Bartley GE, Yokoyama W, Young SA, Anderson WHK, Hung S-C, Albers DR, Langhorst ML, Kim H. 2010. Hypocholesterolemic effects of hydroxypropyl methylcellulose are mediated by altered gene expression in hepatic bile and cholesterol pathways of male hamsters. J Nutr 140:1255–60.
3. Bellaver B, de Souza DG, Souza DO, Quincozes-Santos A. 2014. Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats. Toxicol In Vitro 28:479–84.
4. Chen Q, Wang E, Ma L, Zhai P. 2012. Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice. Lipids Health Dis 11:56–63.
5. Daiki M, Yutaka M, Kazumi Y. 2003. Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci 73:1393–400.
6. Daviglus ML, Talavera GA, Avilés-Santa ML, Allison M, Cai J, Criqui MH, Gellman M, Giachello AL, Gouskova N, Kaplan RC. 2012. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 308:1775–84.
7. Delmas D, Aires V, Limagne E, Dutartre P, Mazué F, Ghiringhelli F, Latruffe N. 2011. Transport, stability, and biological activity of resveratrol. Ann N Y Acad Sci 1215:48–59.
8. De Santi C, Pietrabissa A, Mosca F, Pacifici G. 2000. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 30:1047–54.
9. Gomez LS, Zancan P, Marcondes MC, Ramos-Santos L, Meyer-Fernandes JR, Sola-Penna M, Da Silva D. 2013. Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie 95:1336–43.
10. Hofmann AF. 1999. Bile acids: the good, the bad, and the ugly. Physiology 14:24–9.
11. Jeon S-M, Lee S-A, Choi M-S. 2014. Antiobesity and vasoprotective effects of resveratrol in apoe-deficient mice. J Med Food 17:310–6.
12. Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. 2011. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemoth Pharm 68:593–601.
13. Kim H, Bartley GE, Rimando AM, Yokoyama W. 2010. Hepatic gene expression related to lower plasma cholesterol in hamsters fed high-fat diets supplemented with blueberry peels and peel extract. J Agric Food Chem 58:3984–91.
14. Kolouchova I, Melzoch K, Smidrkal J, Filip V. 2005. The content of resveratrol in vegetables and fruit. Chem Listy 99:492–5.
15. Lancon A, Delma D, Osman H, Thenot J-P, Jannin B, Latruffe N. 2004. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Co 316:1132–7.
16. Langston TB, Hylemon PB, Grogan W. 2005. Over-expression of hepatic neutral cytosolic cholesteryl ester hydrolase in mice increases free cholesterol and reduces expression of HMG-CoAR, CYP27, and CYP7A1. Lipids 40:31–8.
17. Lasa A, Churruca I, Eseberri I, Andrés-Lacueva C, Portillo MP. 2012. Dilapidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Mol Nutr Food Res 56:1559–68.
18. Leanca CC, Nunes VS, Nakandakare ER, de Faria EC, Quintao ECR. 2013. Does plasma HDL-C concentration interact with whole-body cholesterol metabolism? Nutr Metab Cardiovas 23:279–84.
19. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. 2009. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89:147–91.
20. Meier PJ, Stieger B. 2002. Bile salt transporters. Annu Rev Physiol 64:635–61.
21. Park S-J, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148:421–33.
22. Patel KR, Scott E, Brown VA, Gescher AJ. Steward WP, Brown K. 2011. Clinical trials of resveratrol. Ann NY Acad Sci 1215:161–9.
23. Polycarpou E, Meira LB, Carrington S, Tyrrell E, Modjtahedi H, Carew MA. 2013. Resveratrol 3-O-d-glucuronide and resveratrol 4′-O-d-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest. Mol Nutr Food Res 57:1708–17.
24. Shao D, Bartley GE, Yokoyama W, Pan Z, Zhang H, Zhang A. 2013. Plasma and hepatic cholesterol-lowering effects of tomato pomace, tomato seed oil and defatted tomato seed in hamsters fed with high-fat diets. Food Chem 139:589–96.
25. Spady DK. 1992. Hepatic clearance of plasma low density lipoproteins. Semin Liver Dis 373–85.
26. Tai MH, Chen PK, Chen PY, Wu MJ, Ho CT, Yen JH. 2014. Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells. Mol Nutr Food Res 58:2133–45.
27. Villanueva MJ, Yokoyama WH, Hong YJ, Barttley GE, Rupérez P. 2011. Effect of high-fat diets supplemented with okara soybean by-product on lipid profiles of plasma, liver and faeces in Syrian hamsters. Food Chem 124:72–9.
28. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Mérillon J-M. 2003. Distribution of [14 C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72:2219–33.
29. Walker J, Schueller K, Schaefer LM, Pignitter M, Esefelder L, Somoza V. 2014. Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations. Food Funct 5:74–84.
30. Wang H, Yang Y-J, Qian H-Y, Zhang Q, Xu H, Li J-J. 2012. Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev 17:437–48.
31. Wilson TA, Nicolosi RJ, Rogers EJ, Sacchiero R, Goldberg DJ. 1998. Studies of cholesterol and bile acid metabolism, and early atherogenesis in hamsters fed GT16-239, a novel bile acid sequestrant (BAS). Atherosclerosis 140:315–24.
32. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB. 2002. Human, rat, and mouse metabolism of resveratrol. Pharm Res 19:1907–14.
33. Zhao W, Li J, He X, Lv O, Cheng Y, Liu R. 2014. In vitro steatosis hepatic cell model to compare the lipid-lowering effects of pomegranate peel polyphenols with several other plant polyphenols as well as its related cholesterol efflux mechanisms. Toxicol Rep 1:945–54.
34. Zhu L, Luo X, Jin Z. 2008. Effect of resveratrol on serum and liver lipid profile and antioxidant activity in hyperlipidemia rats. Asian Austral J Anim 21:890–5.